MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 1 filers reported holding MOMENTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $21,049,000 | -25.8% | 401,075 | -53.0% | 0.01% | -28.6% |
| Q2 2020 | $28,376,000 | +46.4% | 852,896 | +19.7% | 0.01% | +27.3% |
| Q1 2020 | $19,382,000 | +48.8% | 712,544 | +8.0% | 0.01% | +57.1% |
| Q4 2019 | $13,022,000 | +70.2% | 660,010 | +11.8% | 0.01% | +40.0% |
| Q3 2019 | $7,650,000 | +7.3% | 590,210 | +3.1% | 0.01% | +25.0% |
| Q2 2019 | $7,130,000 | -12.1% | 572,669 | +2.6% | 0.00% | -20.0% |
| Q1 2019 | $8,114,000 | +49.1% | 558,395 | +13.3% | 0.01% | +25.0% |
| Q4 2018 | $5,443,000 | -51.9% | 492,950 | +14.5% | 0.00% | -50.0% |
| Q3 2018 | $11,319,000 | +35.7% | 430,351 | +5.5% | 0.01% | +33.3% |
| Q2 2018 | $8,340,000 | +18.1% | 407,789 | +4.8% | 0.01% | +20.0% |
| Q1 2018 | $7,064,000 | +23.6% | 389,152 | -5.0% | 0.01% | 0.0% |
| Q4 2017 | $5,713,000 | -21.2% | 409,519 | +4.5% | 0.01% | -16.7% |
| Q3 2017 | $7,249,000 | +19.8% | 391,792 | +9.4% | 0.01% | 0.0% |
| Q2 2017 | $6,052,000 | +54.6% | 358,055 | +22.1% | 0.01% | +50.0% |
| Q1 2017 | $3,915,000 | +4.3% | 293,238 | +17.6% | 0.00% | 0.0% |
| Q4 2016 | $3,752,000 | +43.5% | 249,268 | +11.5% | 0.00% | +33.3% |
| Q3 2016 | $2,614,000 | -10.4% | 223,550 | -17.2% | 0.00% | -25.0% |
| Q2 2016 | $2,918,000 | +18.4% | 270,121 | +1.3% | 0.00% | +33.3% |
| Q1 2016 | $2,464,000 | -60.8% | 266,647 | -37.0% | 0.00% | -62.5% |
| Q4 2015 | $6,278,000 | +58.8% | 422,984 | +75.6% | 0.01% | +33.3% |
| Q3 2015 | $3,954,000 | -0.5% | 240,934 | +38.4% | 0.01% | +20.0% |
| Q2 2015 | $3,972,000 | +87.6% | 174,109 | +25.0% | 0.01% | +66.7% |
| Q1 2015 | $2,117,000 | +31.9% | 139,274 | +4.5% | 0.00% | +50.0% |
| Q4 2014 | $1,605,000 | +9.7% | 133,283 | +3.4% | 0.00% | 0.0% |
| Q3 2014 | $1,463,000 | -10.4% | 128,957 | -4.6% | 0.00% | -33.3% |
| Q2 2014 | $1,633,000 | +3.4% | 135,113 | -0.4% | 0.00% | 0.0% |
| Q1 2014 | $1,580,000 | -32.2% | 135,619 | +2.8% | 0.00% | -25.0% |
| Q4 2013 | $2,332,000 | -21.6% | 131,864 | -33.5% | 0.00% | -33.3% |
| Q3 2013 | $2,976,000 | +80.5% | 198,228 | +79.6% | 0.01% | +50.0% |
| Q2 2013 | $1,649,000 | – | 110,382 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,790,400 | $55,055,000 | 4.79% |
| Camber Capital Management LP | 3,250,000 | $64,123,000 | 3.26% |
| Avidity Partners Management LP | 200,000 | $3,946,000 | 2.49% |
| Asymmetry Capital Management, L.P. | 62,585 | $1,235,000 | 2.21% |
| Palo Alto Investors LP | 1,685,372 | $33,252,000 | 1.83% |
| Monashee Investment Management LLC | 90,223 | $1,780,000 | 1.66% |
| Greencape Capital Pty Ltd | 217,078 | $4,283,000 | 1.65% |
| Redmile Group, LLC | 3,237,700 | $63,880,000 | 1.53% |
| Ghost Tree Capital, LLC | 400,000 | $7,892,000 | 1.50% |
| Perceptive Advisors | 2,835,637 | $55,947,000 | 1.11% |